Literature DB >> 14563340

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

M Moscucci1, K A A Fox, Christopher P Cannon, W Klein, José López-Sendón, G Montalescot, K White, R J Goldberg.   

Abstract

AIMS: There have been no large observational studies attempting to identify predictors of major bleeding in patients with acute coronary syndromes (ACS), particularly from a multinational perspective. The objective of our study was thus to develop a prediction rule for the identification of patients with ACS at higher risk of major bleeding. METHODS AND
RESULTS: Data from 24045 patients from the Global Registry of Acute Coronary Events (GRACE) were analysed. Factors associated with major bleeding were identified using logistic regression analysis. Predictive models were developed for the overall patient population and for subgroups of patients with ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina. The overall incidence of major bleeding was 3.9% (4.8% in patients with STEMI, 4.7% in patients with NSTEMI and 2.3% in patients with unstable angina). Advanced age, female sex, history of bleeding, and renal insufficiency were independently associated with a higher risk of bleeding (P<0.01). The association remained after adjustment for hospital therapies and performance of invasive procedures. After adjustment for a variety of potential confounders, major bleeding was significantly associated with an increased risk of hospital death (adjusted odds ratio 1.64, 95% confidence interval 1.18, 2.28).
CONCLUSIONS: In routine clinical practice, major bleeding is a relatively frequent non-cardiac complication of contemporary therapy for ACS and it is associated with a poor hospital prognosis. Simple baseline demographic and clinical characteristics identify patients at increased risk of major bleeding.

Entities:  

Mesh:

Year:  2003        PMID: 14563340     DOI: 10.1016/s0195-668x(03)00485-8

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  143 in total

1.  Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

Authors:  Kent Feng; Vipul Gupta; Enrique Terrazas; Yerem Yeghiazarians; Thomas Ports; Gabriel Gregoratos; Mehdi Tavakol; John Paul Roberts; Andrew Boyle
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey.

Authors:  Michael A Barras; Carl M J Kirkpatrick; Bruce Green
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

3.  'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.

Authors:  W Dewilde; F W A Verheugt; N Breet; J J Koolen; J M Ten Berg
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

4.  Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.

Authors:  Sumeet Subherwal; Eric D Peterson; David Dai; Laine Thomas; John C Messenger; Ying Xian; Ralph G Brindis; Dmitriy N Feldman; Shaun Senter; Lloyd W Klein; Steven P Marso; Matthew T Roe; Sunil V Rao
Journal:  J Am Coll Cardiol       Date:  2012-05-22       Impact factor: 24.094

5.  Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.

Authors:  Paola Sanchez-Pena; Jean-Sébastien Hulot; Saïk Urien; Annick Ankri; Jean-Philippe Collet; Rémi Choussat; Philippe Lechat; Gilles Montalescot
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

Review 6.  Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Authors:  David H Fitchett; Bjug Borgundvaag; Warren Cantor; Eric Cohen; Sanjay Dhingra; Stephen Fremes; Milan Gupta; Michael Heffernan; Heather Kertland; Mansoor Husain; Anatoly Langer; Eric Letovsky; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

7.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

8.  The bleeding risk score as a mortality predictor in patients with acute coronary syndrome.

Authors:  José Carlos Nicolau; Humberto Graner Moreira; Luciano Moreira Baracioli; Carlos Vicente Serrano; Felipe Galego Lima; Marcelo Franken; Roberto Rocha Giraldez; Fernando Ganem; Roberto Kalil Filho; José Antônio Franchini Ramires; Roxana Mehran
Journal:  Arq Bras Cardiol       Date:  2013-11-12       Impact factor: 2.000

Review 9.  Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management.

Authors:  Magdalena Doktorova; Zuzana Motovska
Journal:  Crit Care       Date:  2013-09-27       Impact factor: 9.097

Review 10.  Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis.

Authors:  Patrick Yachimski; Chin Hur
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.